Burlington, MA –  RedShift BioAnalytics, Inc. (RedShiftBio) announced its award winning AQS3™pro, based on Microfluidic Modulation Spectroscopy (MMS) technology, is now available in Japan, following the appointment of Primetech as exclusive distributor.  This partnership follows the announcement in May of appointing Topbiox as its distributor in China, and continuing RedShiftBio’s response to the rapid growth […]

TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the signing of three new European distributor agreements to promote HTG products and services in Nordic and Eastern European Countries with BioNordika (Denmark), Explorea (Czech Republic), and ELTA 90 (Bulgaria). “Expanding and […]

LONDON — Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, and the Tecan Group (SIX Swiss Exchange: TECN) announce a partnership to deepen the integration between Synthace’s Antha software and Tecan’s Te-Chrom™ automated chromatography system to unlock the full potential of miniaturized protein purification. The new […]

Project Will Evolve Data Sharing Paradigm with the Goal of Rapidly Bringing Data from ongoing Clinical Trials to the Research Community BOSTON, MANHATTAN BEACH, CALIF. –  Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced that it has been selected by the Pancreatic Cancer Action Network (PanCAN) to build a customized, integrated health data platform […]

Auckland, NZ – Boston-based antibody discovery services company Abveris has partnered with Biomatters to incorporate the Geneious Biologics data analysis platform into their antibody discovery workflow. In collaboration, a new Single Clone Antibody Annotator pipeline has been developed. With a rapidly growing customer base and a wide range of antibody discovery services, Abveris plans to […]

Lonza has collaborated with CELLINK to offer a comprehensive 3-dimensional (3D) bioprinting solution designed to advance complete 3D cell culture workflows The solution combines CELLINK’s 3D bioprinting instruments and bioinks with Lonza’s primary cells and culture media, to meet the needs of cell biologists for enhanced bioprinting of complex 3D human tissue constructs Under the […]

Burlington, MA –  RedShift BioAnalytics, Inc. (RedShiftBio) announces its award winning AQS3™pro, based on Microfluidic Modulation Spectroscopy (MMS) technology, is now available in China, following the appointment of Beijing-based Topbiox as exclusive distributor. Designed specifically for protein characterization applications in the biopharmaceutical industry, the technology has already seen wide adoption in the analytical toolkit of […]

Merck and 10x Genomics, Inc., (Nasdaq: TXG), a single cell and spatial genomics technologies company, today announced that they have developed a powerful new option for biological experiments. First solution for simultaneous gene perturbation measurement and unbiased single-cell gene expression Provides researchers with more detailed information to better understand the relationship between specific genes and […]

The Seven Bridges Bioinformatics Ecosystem Supports the Critical Turnaround Times for the CareDx AlloSure® 3.0 Workflow BOSTON—Seven Bridges, the industry-leading bioinformatics ecosystem provider, announced today a new partnership with CareDx, Inc. (Nasdaq: CDNA) supporting the CareDx AlloSure 3.0 workflow. CareDx is a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value […]

Agreement calls for identifying IDH gene mutations using Oncomine Precision Assay and the Ion Torrent Genexus System, a new turnkey, next-generation sequencing solution CARLSBAD, Calif. — Thermo Fisher Scientific today announced that it has expanded its strategic partnership with Agios Pharmaceuticals by adding the co-development of a second companion diagnostic (CDx) for oncology to their existing […]